Company Directory - Aurobindo Pharma Limited
Company Details - Aurobindo Pharma Limited
Aurobindo Pharma Limited
WebsiteHyderabad, India
ISIN: INE982B01021
Aurobindo Pharma Limited is an Indian multinational pharmaceutical company involved in the manufacturing and development of generic drugs, biosimilars, and complex generics, serving markets around the globe.
CCI Score
CCI Score: Aurobindo Pharma Limited
-53.10
0.03%
Latest Event
Aurobindo Pharma's Electoral Bonds Donation
Aurobindo Pharma donated Rs 52 crore through electoral bonds with a majority of the funds benefiting the BJP, raising serious concerns about corporate financial support for authoritarian political agendas and the opaque nature of electoral bond funding.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
QUISLING
Aurobindo Pharma Limited is currently rated as a Quisling.
Latest Events
- MAR222024
Aurobindo Pharma donated Rs 52 crore through electoral bonds with a majority of the funds benefiting the BJP, raising serious concerns about corporate financial support for authoritarian political agendas and the opaque nature of electoral bond funding.
-80
Political Contributions and Lobbying Efforts
March 19
The company's substantial donation via electoral bonds, largely channeled to the BJP—a party criticized for authoritarian tendencies—demonstrates a troubling alignment with far-right political interests. The use of opaque financial instruments like electoral bonds further undermines transparency and accountability, contributing to a corporate complicity in supporting policies that may erode democratic norms.
Aurobindo Pharma's Electoral Bonds Donation: BJP Receives Majority - Goodreturns
- MAR222024
Reports indicate that Aurobindo Pharma contributed Rs 34.5 crore through electoral bonds to major political parties, including the BJP. This donation, made via opaque funding channels, raises concerns about corporate complicity in supporting authoritarian practices that undermine democratic accountability.
-40
Political Contributions and Lobbying Efforts
March 19
Aurobindo Pharma’s donation of Rs 34.5 crore, as highlighted in the Times of India report, evidences problematic political contributions. The use of electoral bonds, which lack transparency, and the alignment with parties that have displayed authoritarian tendencies, particularly the BJP, contribute to a negative evaluation from an anti-fascist perspective.
BJP, BRS & Cong top recipients of donations from pharma firms
- FEB062024
A congressional record highlights Aurobindo Pharma's heavy reliance on PRC-based suppliers with documented ties to forced labor practices and military-linked organizations. Recurring quality issues, supplier recalls, and signs of regulatory capture across its supply chain raise serious ethical concerns, undermining labor rights and posing risks to public safety. These conditions indirectly contribute to authoritarian economic practices and complicity in repressive structures.
-90
Business Practices and Ethical Responsibility
March 19
Aurobindo Pharma’s supply chain is critically dependent on several suppliers from the People’s Republic of China that have documented ties to forced labor and military-civil fusion policies. The company’s repeated product recalls and quality issues, combined with evidence of corruption and lenient regulatory oversight, indicate severe ethical lapses in supply chain management that align indirectly with authoritarian practices.
Documents for the Record – Congressional Hearing on Economic Competition
-70
Economic and Structural Influence
March 19
Economic benefits such as government subsidies and favorable regulatory treatment have allowed Aurobindo Pharma to expand its operations despite multiple quality and compliance issues. This environment of regulatory capture and economic collusion not only undermines consumer safety but also reinforces structural dependencies that can indirectly support authoritarian practices.
Documents for the Record – Congressional Hearing on Economic Competition
- FEB022024
An in‐depth report on Aurobindo Pharma reveals serious ethical and regulatory issues. The company relies heavily on PRC suppliers linked to forced labor, military industrial ties, and potential human rights abuses. Combined with reports of workplace safety failures, environmental violations, and rampant regulatory capture—a pattern of corruption and government favoritism—the firm’s practices raise significant concerns about their complicity in undermining standards and contributing to authoritarian economic agendas.
-70
Labor Relations and Human Rights Practices
March 19
Labor Relations and Human Rights Practices: Multiple reports of environmental hazards, workplace safety failures, and allegations of exploited labor underscore a troubling record that compromises worker rights and community safety, reflecting practices that indirectly support exploitative and authoritarian operational regimes.
-80
Supply Chain Ethics
March 19
Supply Chain Ethics: The company’s heavy reliance on PRC suppliers, several of which are linked to forced labor, military industrial structures, and violations of U.S. pharmaceutical standards (including bans and recalls), reveals a deep-seated ethical breach in its sourcing practices.
-60
Regulatory Capture
March 19
Regulatory Capture and Economic Collaboration: Aurobindo Pharma’s history of regulatory warnings, product recalls, and involvement in corruption scandals indicate a pattern of regulatory capture. This reflects undue influence over regulatory bodies and suggests economic practices that favor alignment with authoritarian policies and government subsidies.
- NOV082023
In November 2023, shortly after being awarded a government subsidy under the PLI scheme for Penicillin G production, Aurobindo Pharma donated Rs 25 crore in electoral bonds to the BJP. This move raises concerns over potential political quid pro quo and corporate complicity in enabling authoritarian practices.
-80
Public and Political Behavior
March 19
Aurobindo Pharma's sizable donation via electoral bonds—making up over 72% of its total electoral bond contributions—immediately following receipt of substantial government subsidies under the PLI scheme, indicates an explicit alignment with the ruling BJP. This act demonstrates corporate behavior that potentially reinforces authoritarian policies, thereby contributing to a political environment where corporate money may undermine democratic accountability.
-70
Economic and Structural Influence
March 19
The decision to donate such a large sum in electoral bonds comes on the heels of receiving lucrative government incentives, suggesting a problematic intertwining of corporate economics and political patronage. This not only raises questions about regulatory capture, but also implies that economic benefits may be used to secure favorable political outcomes, further supporting authoritarian governance structures.
- NOV212022
Aurobindo Pharma made significant political contributions via electoral bonds, facilitating donations to the BJP. This involvement raises concerns about the company’s complicity in supporting authoritarian practices, especially given the controversial role of its director in the Delhi liquor policy case.
-70
Political Contributions and Lobbying Efforts
March 19
Aurobindo Pharma’s purchase of electoral bonds, which were largely redeemed by the BJP, illustrates a direct channeling of corporate funds to an authoritarian political force. The use of electoral bonds obscures the source and destination of funds, undermining transparency and contributing to the entrenchment of authoritarian practices.
-50
Executive Political Engagement
March 19
The involvement of Aurobindo Pharma’s director, who turned approver in a high-profile case linked to controversial electoral bond transactions, suggests problematic executive political engagement. This connection between top management and politically charged donations undermines democratic accountability and raises red flags about corporate governance.
- JUL182013
The company has been accused of obstructing workers' efforts to unionize and transferring employees involved in union organizing, raising serious concerns about its labor relations and human rights practices.
-60
Labor Relations and Human Rights Practices
March 19
Allegations indicate that Aurobindo Pharma prevented workers from forming a union and transferred employees involved in union organizing. Such anti-union practices undermine labor rights and workplace democracy, contributing to a broader authoritarian dynamic through suppression of worker protections.
Aurobindo Pharma is Accused of Preventing Workers From Unionizing
Alternatives
Tokyo, Japan
-7.42
North Chicago, United States
-31.53
Corporation
-13.53
Bagsværd, Denmark
18.81
Barcelona, Spain
57.57
Japan
26.16
Brentford, United Kingdom
18.03
Kenilworth, United States
2.89
Basel, Switzerland
-19.75
Petah Tikva, Israel
-21.90
Industries
- 325411
- Medicinal and Botanical Manufacturing
- 325412
- Pharmaceutical Preparation Manufacturing
- 424210
- Drugs and Druggists' Sundries Merchant Wholesalers